Literature DB >> 17081187

Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature.

H Stokes-Lampard1, S Wilson, C Waddell, A Ryan, R Holder, S Kehoe.   

Abstract

BACKGROUND: Vaginal vault smears are used to detect persisting neoplasia of the lower genital tract after hysterectomy. Recent data suggest both widespread use and uncertain evidence of their effectiveness.
OBJECTIVES: To identify and synthesise evidence on the use and effectiveness of vaginal vault smears and to assess the quality. SEARCH STRATEGY 'vault smear' OR 'vaginal vault smear' OR 'cervical vault smear' OR ('Hysterectomy') AND ('Follow up' OR 'Smear'). SELECTION CRITERIA Primary research, women who had a hysterectomy and were followed up by vault cytology. DATA COLLECTION AND ANALYSIS: Systematic search (eight electronic databases), supplemented by contact with experts and review of bibliographies. Two independent reviewers determined eligibility/validity and extracted data concerning test performance characteristics. Quality was assessed according to the established criteria.
RESULTS: Of 441 unique references, only 19 were suitable. Quality of studies varied considerably and few were of 'high' methodological quality. Studies were geographically diverse, and were published over more than 40 years in 16 journals. From the higher scoring papers, there were 11 659 hysterectomies [6546, benign; 76, cervical intraepithelial neoplasia (CIN) I/CIN II; 5037, CIN III]. Proportions of abnormal vault smears and abnormal biopsies during follow up increased with worsening histology at hysterectomy (P < 0.0001 and P = 0.0001). There was only one report of vaginal cancer subsequent to hysterectomy for CIN and insufficient data to allow for reliable meta-analysis.
CONCLUSIONS: Vault smears cause anxiety, consume resources and their value is largely unproven. Inconsistency of study design and limited methodological quality means that the value of vault smears could not be established. High-quality research is required to ensure that the guidelines are evidence based.

Entities:  

Mesh:

Year:  2006        PMID: 17081187     DOI: 10.1111/j.1471-0528.2006.01099.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  9 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Cervical cancer screening for survivors diagnosed with cancer before age 25.

Authors:  Olivia L Tseng; John J Spinelli; Martin Dawes; Mary L McBride
Journal:  J Cancer Surviv       Date:  2017-01-27       Impact factor: 4.442

3.  Making Sense of Cervical Cancer Screening Guidelines and Recommendations.

Authors:  Michelle Davis; Sarah Feldman
Journal:  Curr Treat Options Oncol       Date:  2015-12

4.  Improving Knowledge and Awareness of Human Papillomavirus-Associated Gynecologic Cancers: Results from the National Comprehensive Cancer Control Program/Inside Knowledge Collaboration.

Authors:  Julie S Townsend; Mary Puckett; Cynthia A Gelb; Martin Whiteside; Julia Thorsness; Sherri L Stewart
Journal:  J Womens Health (Larchmt)       Date:  2018-08       Impact factor: 2.681

Review 5.  The impact of human papillomavirus vaccination on cervical cancer prevention efforts.

Authors:  L Stewart Massad; Mark Einstein; Evan Myers; Cosette M Wheeler; Nicolas Wentzensen; Diane Solomon
Journal:  Gynecol Oncol       Date:  2009-05-01       Impact factor: 5.482

6.  Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg.

Authors:  Sanele S Mbuyisa; Thandekile L Khumalo; Bongumusa S Makhathini; Jagidesa Moodley
Journal:  S Afr Fam Pract (2004)       Date:  2022-03-31

7.  Laparoscopic upper vaginectomy for post-hysterectomy high risk vaginal intraepithelial neoplasia and superficially invasive vaginal carcinoma.

Authors:  Youn Jin Choi; Soo Young Hur; Jong Sup Park; Keun Ho Lee
Journal:  World J Surg Oncol       Date:  2013-06-03       Impact factor: 2.754

8.  Variation in NHS utilisation of vault smear tests in women post-hysterectomy: A study, using routinely collected datasets.

Authors:  Helen J Stokes-Lampard; John Macleod; Sue Wilson
Journal:  BMC Womens Health       Date:  2008-03-28       Impact factor: 2.809

Review 9.  Current Cervical Carcinoma Screening Guidelines.

Authors:  Megan J Schlichte; Jacqueline Guidry
Journal:  J Clin Med       Date:  2015-05-07       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.